Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. EFFECT Other Notice of Effectiveness
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. S-3 Offering Registration Statement
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Executive or director change
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale Chief Financial Officer sold 50,060 shares at $2.92 ($146,175)
  20. 4 Open-market sale Chief Executive Officer sold 129,501 shares at $2.92 ($378,143)

Page 4 of 68 · 1,358 filings